Clinical Trials Browser

Phase 1/2 × INDUSTRY × pegaspargase × Clear all

NCT04509466 2024-03-07

Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL

Phase 1/2 Terminated

Lymphoma, Extranodal NK-T-Cell

NCT01251809 2013-05-20

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Phase 1/2 Terminated

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma